XM does not provide services to residents of the United States of America.
N
N

NNGroup

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Top of the Street: Kuehne + Nagel, NN Group, ASR Nederland, Euronext

BUZZ-Top of the Street: Kuehne + Nagel, NN Group, ASR Nederland, Euronext A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays raises Kuehne + Nagel KNIN.S to "equal-weight" from "underweight", pointing to high exposure to sea freight and leaner corporate structure ** J.P.Morgan upgrades Dutch insurer NN Group NV NN.AS to "overweight" from "neutral", seeing it as a "strong" beneficiary of Dutch pensions reform ** The broker also downgrades ASR Nederl
K
N

JPM upgrades NN Group on Dutch pension reform potential, cuts ASR

BUZZ-JPM upgrades NN Group on Dutch pension reform potential, cuts ASR ** J.P.Morgan upgrades Dutch insurer NN Group NV NN.AS to "overweight" from "neutral" seeing it as a "strong" beneficiary of Dutch pensions reform ** It downgrades its peer ASR Nederland ASRNL.AS to "neutral" from "overweight" on lower estimates for non-life insurance and fee-ba
N

Adyen, AstraZeneca, Auto Trader

EUROPE RESEARCH ROUNDUP-Adyen, AstraZeneca, Auto Trader July 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen, AstraZeneca and Auto Trader, on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Jefferies cuts target price to EUR 1,695 from EUR 1,821 * AstraZeneca AZN.L : Jefferies raises target price to 11,700p from 11,300p * Auto Trader AUTOA.L : Jefferies raises target price to 935p from 830p * Halma HLMA.L : HSBC raises target pri
3
A
A
A
B
C
C
C
E
E
E
G
H
R
S
S
V
A
A
A
A
A
B
N
N
S

Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court

UPDATE 1-Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court Updates total amount of assets under management in paragraph 2, indicates PGGM as pension investor in pararaph 6 AMSTERDAM, May 28 (Reuters) - A group of around 40 large European and American institutional investors on Tuesday urged companies to refrain from taking shareholders to court over disagreements relating to their proposals.
S
N

Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court

Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court AMSTERDAM, May 28 (Reuters) - A group of around 40 large European and American institutional investors on Tuesday urged companies to refrain from taking shareholders to court over disagreements relating to their proposals. The group, which represents $4.4 trillion in assets under management, highlighted the lawsuit filed by Exxon Mobil XOM.N against two activist groups, in which the oil company seeks to bar thei
S
N

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.